Lebanon vs Togo: HIV-positive TB patients on ART (antiretroviral therapy)
Lebanon
100.0%
in 2024
Togo
100.0%
in 2024
Lebanon rank
1st
Togo rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Lebanon
- Togo
How they compare
Lebanon currently reports 100.0% against 100.0% in Togo, a difference of 0.0%.
The two have swapped places 5 times across 16 shared years of data; in 2008 it was Lebanon ahead.
Lebanon ranks 1st and Togo ranks 1st of 144 countries.
Across the 3 decades both report, Lebanon averaged higher in 2 and Togo in 1.
Head to head by decade
| Decade | Lebanon | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 33.0% | 67.0% | Lebanon |
| 2010s | 88.5% | 85.1% | 3.4% | Lebanon |
| 2020s | 91.8% | 99.5% | 7.8% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Lebanon or Togo?
- Lebanon, at 100.0% against 100.0% in Togo as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Lebanon and Togo?
- 0.0%, with Lebanon ahead.
- How many years of comparable data are there for Lebanon and Togo?
- 16 years are reported by both, from 2008 to 2024.
- How do Lebanon and Togo rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Lebanon ranks 1st and Togo ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.